Open AccessCRITERIA FOR CHOOSING THE METHOD OF CORRECTION OF DISBACTERIOSIS OF AUTHORITIES ORAL CAVITY
Author(s) -
Карен Караков,
Tatyana Vlasova,
Artur Oganyan,
Araksia Khachaturyan,
Vera Timircheva,
Kristina Aslamova,
V. I. Solovieva
Publication year - 2020
Publication title -
problemy stomatologii
Language(s) - English
Resource type - Journals
eISSN - 2412-9461
pISSN - 2077-7566
DOI - 10.18481/2077-7566-20-16-2-17-21
Subject(s) - probiotic , regimen , medicine , dysbiosis , guideline , streptococcus salivarius , intensive care medicine , streptococcus , biology , pathology , bacteria , genetics , disease
Subject. The article presents data from a comparative analysis of the inclusion of an oral probiotic in the traditional treatment regimen for oral candidiasis. The goal is to increase the effectiveness of the traditional treatment regimen by introducing a probiotic for the oral mucosa containing the Streptococcus salivarius K12 strain. Methodology. The study involved 30 patients with a diagnosis of "oral dysbiosis" aged 20 to 60 years, who were divided into 2 groups: control (15 people) and main (15 people). In the control group, conventional medical treatment was carried out with the inclusion of probiotic and antifungal drugs in the general therapy (according to the scheme), the probiotic Bactoblis was introduced into the main drug plan. Results. The proposed treatment regimen using the latest generation probiotic for the oral mucosa containing the Streptococcus salivarius K12 strain, in combination with the traditional treatment regimen for oral dysbiosis, was more effective than conventional complex therapy. Analysis of the clinical data of therapeutic measures in patients of the main group showed stabilization of the process on the 5th day from the start of therapy compared with the control, in which the improvement was diagnosed on the 10th day. Findings. The results indicate a greater effectiveness of therapy compared to the generally accepted method for the treatment of oral dysbiosis when a probiotic containing the Streptococcus salivarius K12 strain is included in the traditional regimen, which can serve as a guideline for practitioners in choosing a treatment plan for oral dysbiosis.